Home / Addiction / When It Comes To Muscular Dystrophy Drugs, Is It Always Better To Buy American? quoting : American Council on Science and Health
alibaba.com, cpa campaign, lead generation, lead campaign, smart match lander, intelligent lander, a

When It Comes To Muscular Dystrophy Drugs, Is It Always Better To Buy American? quoting : American Council on Science and Health

according to And if we know that’s the case, is it always better to buy American?
The prevalence in young males of Duchenne’s or Becker’s Muscular Dystrophy in the United States is 1.38/10,000.
Until last week the only company making this drug was located in the UK and cost US patients about $1,600 annually.
One exception is when the drug is not manufactured by an American company, which, until last week was the case for deflazacort.
Based upon CDC statistics about 30% of these patients use a steroid, deflazacort, that maintains their mobility by stabilizing their muscle strength.

When It Comes To Muscular Dystrophy Drugs, Is It Always Better To Buy American?

as informed in And if we know that’s the case, is it always better to buy American?
The prevalence in young males of Duchenne’s or Becker’s Muscular Dystrophy in the United States is 1.38/10,000.
Until last week the only company making this drug was located in the UK and cost US patients about $1,600 annually.
One exception is when the drug is not manufactured by an American company, which, until last week was the case for deflazacort.
Based upon CDC statistics about 30% of these patients use a steroid, deflazacort, that maintains their mobility by stabilizing their muscle strength.

as informed in

Muscular Dystrophy Medication Outrageously Priced

The pharmaceutical industry is experiencing more controversy over high-priced drugs with Emflaza, a drug to treat Duchenne muscular dystrophy, being priced at $89,000-a-year.
Muscular dystrophy is caused by a mutation in the gene for the protein dystrophin.
There was also much we did not know about using the drug in the Duchenne patient population including proper dosing, potential side effects and drug-to-drug interactions.”Duchenne muscular dystrophy is the most common form of muscular dystrophy with an average life expectancy of 26.
“Marathon’s apparent abuse of government-granted exclusivity periods and incentives to sell what should be a widely available drug for US$89,000 a year is unconscionable.
According to the Pharmaceutical Journal, this has raised concerns about why the drug is priced so high in the United States.

about the details read more from here

This content may collect you by Jack Oliver

To follow all the new news about Drug

Check Also

picture.jpg

Child protective services face mounting numbers due, mainly, to parental drug abuse statewide & in Lancaster province

  Monday marks the begain of a 3-day gathering in Calgary to talk about addictions …